546 / 1241
220 patients – 9 institutions
60 Gy + TMZ + 72 Gy/2,4 Gy
IMRT SIB guided by MR spectroscopy
Global survival
MRI T1, Flair, diff, Perf + spectro
/2months
Randomization
MRI T1, Flair, diff, Perf + spectro
60 Gy + TMZ
SPECTRO GLIO
Newly Diagnosed Glioblastoma
Prospective multicentric phase III trial- Coordination Anne Laprie
Promoted by Institut Claudius Regaud– financed by French national cancer institute
11